Exportar registro bibliográfico


Metrics:

Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis (2017)

  • Authors:
  • USP affiliated authors: MALHEIROS, DENISE MARIA AVANCINI COSTA - FM ; WORONIK, VIKTORIA - FM
  • Unidade: FM
  • DOI: 10.1007/s40620-015-0252-7
  • Subjects: INFLAMAÇÃO; NEFROPATIAS; PROGNÓSTICO; IMUNOHISTOQUÍMICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso à fonteDOI
    Informações sobre o DOI: 10.1007/s40620-015-0252-7 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      DIAS, Cristiane B.; MALAFRONTE, Patrıcia; LEE, Jin; et al. Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis. Journal of Nephrology, Milano, v. 30, n. 1, p. 87-94, 2017. Disponível em: < https://link.springer.com/article/10.1007/s40620-015-0252-7 > DOI: 10.1007/s40620-015-0252-7.
    • APA

      Dias, C. B., Malafronte, P., Lee, J., Resende, A., Jorge, L., Pinheiro, C. C., et al. (2017). Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis. Journal of Nephrology, 30( 1), 87-94. doi:10.1007/s40620-015-0252-7
    • NLM

      Dias CB, Malafronte P, Lee J, Resende A, Jorge L, Pinheiro CC, Malheiros D, Woronik V. Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis [Internet]. Journal of Nephrology. 2017 ; 30( 1): 87-94.Available from: https://link.springer.com/article/10.1007/s40620-015-0252-7
    • Vancouver

      Dias CB, Malafronte P, Lee J, Resende A, Jorge L, Pinheiro CC, Malheiros D, Woronik V. Role of renal expression of CD68 in the long-term prognosis of proliferative lupus nephritis [Internet]. Journal of Nephrology. 2017 ; 30( 1): 87-94.Available from: https://link.springer.com/article/10.1007/s40620-015-0252-7

    Referências citadas na obra
    Mok CC (2012) Understanding lupus nephritis: diagnosis, management, and treatment options. Int J Women’s Health 4:213–222
    Davidson A, Aranow C (2006) Pathogenesis and treatment of systemic lupus erythematosus nephritis. Curr Opin Rheumatol 18:468–475
    Carlos Franco C, Yoo W, Franco D, Xu Z (2010) Predictors of end stage renal disease in African Americans with lupus nephritis. Bull NYU Hosp Jt Dis 68(4):251–256
    Oe Ayodele, Ig Okpechi, Cr Swanepoel (2010) Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis. Nephrology 15:482–490
    Nived O, Hallengren CS, Alm P, Jönsen A, Sturfelt G, Bengtsson AA (2013) An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of Southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome. Scand J Rheumatol 42:383–389
    Giannico G, Fogo AB (2013) Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol 8:138–145
    Wu LH, Yu F, Tan Y, Qu Z, Chen MH, Wang SX, Liu G, Zhao MH (2013) Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int 83:715–723
    Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, Lan HY (1998) Local Macrophage proliferation in human glomerulonephritis. Kidney Int 54:143–151
    Schiffer L, Bethunaickan LR, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MM, Bottinger EP, Davidson A (2008) Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 1(3):1938–1947
    Menke J, Rabacal WA, Byrne KT, Iwata Y, Schwartz MM, Stanley ER, Schwarting A, Kelley VR (2009) Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis. J Am Soc Nephrol 20:2581–2592
    Gonzalo E, Toldos O, Martínez-Vidal MP, Ordoñez MC, Santiago B, Fernández-Nebro A, Loza E, García I, León M, Pablos JL, Galindo M (2012) Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis. Arthritis Res Ther 14:1–8
    Hill GS, Delahousse M, Nochy D, Rémy P et al (2001) Predictive power of second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int 59:304–316
    Marks SD, Williams SJ, Tullus K, Sebire N (2008) Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant 23:3521–3526
    Anders HJ, Ryu M (2011) Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80:915–925
    Ricardo SD, van Goor H, Eddy AA (2008) Macrophage diversity in renal injury and repair. J Clin Invest 118:3522–3530
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
    Weening JJ, D’Agati V, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AG, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura L, Nagatam M, on behalf of the International Society of Nephrology and Renal Pathology Society working group on the classification of lupus nephritis (2004) The Classification of Glomerulonephritis in Systemic Lupus Erythematosus Revisited. J Am Soc Nephrol 15:241–250
    Bombardier C, Gladmann DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630–640
    Sánchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA et al (2012) Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis Rheum 64:3687–3694
    Chen X, Wen Z, Xu W, Xiong S (2013) Granulin exacerbates lupus nephritis via enhancing macrophage M2b polarization. PLoS One 8:1–12
    Alexopoulos E, Seron D, Hartley RB, Cameron JS (1990) Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 37(1):100–109
    Singh RG, Usha, Rathore SS, Behura SK, Singh NK (2012) Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 21:1214–1218
    Rosa RF, Takei K, Araujo NC, Loduca SMA, Szajubok JCM, Chahade WH (2012) Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. J Rheumatol 39(10):1948–1954
    Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CI, Nagaraja HN (2005) Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 16(12):467–473
    Zhao L, David MZ, Hyjek E, Chang A, Meehan SM (2015) M2 macrophage infiltrates in the early stages of ANCA-associated pauci-immune necrotizing GN. Clin J Am Soc 10:54–62
    Tsokos GC (2004) Exploring complement activation to develop biomarkers for systemic lupus erythematosus. Arthritis Reum 50(11):3404–3407
    Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH (2010) The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19(11):1272–1280
    Colares VS, Titan SMO, Pereira AC, Malafronte P, Cardena MM, Santos S, Santos PC, Fridman C, Barros RT, Woronik V (2014) MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population. PLoS One 9(3):1–8

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020